logo
  

Thermo Fisher Gets $193 Mln Contract From U.S. DoD For Pipette Tips - Quick Facts

Thermo Fisher Scientific Inc. (TMO) announced Thursday a $192.5 million contract award from the U.S. Department of Defense (DoD) to ensure reliable domestic production of pipette tips, which are used within research and diagnostic labs to dispense precise amounts of liquid.

In mid-2020, the company announced its own investments to increase pipette tip production capacity to support COVID-19 testing.

With the DoD award, issued on behalf of and in coordination with the U.S. Department of Health and Human Services (HHS), Thermo Fisher will co-invest with the U.S. government in building a new, state-of-the-art, energy efficient manufacturing facility for pipette tips.

Pipette tips are used in vital disease research and in high volumes for processing of diagnostic tests nationally, including COVID-19, during the pandemic.

The new center of excellence in laboratory consumables manufacturing and operations will be in North Carolina and designed in line with Thermo Fisher's carbon neutrality goals. Construction will be fully completed by the third quarter of 2024, with pipette tip manufacturing starting as early as the third quarter of 2023.

The site, expected to create hundreds of new jobs in the region, has the potential for future expansion across a variety of high-demand product lines.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Louisville, Kentucky -based GE Appliances, owned by Chinese home appliances company Haier, is recalling to repair free-standing and slide-in electric and gas ranges due to tip-over risk, the U.S. Consumer Product Safety Commission announced. The recall involves about 132,000 units of electric and gas ranges sold in the United States. In addition, about 12,960 units were sold in Canada. While reporting financial results for the first quarter on Wednesday, United Natural Foods, Inc. (UNFI) affirmed its earnings, adjusted earnings and sales guidance for the full-year 2021. For fiscal 2022, the company continues to project earnings in the range of $3.60 to $3.90 per share and adjusted... Buena, New Jersey-based Teligent Pharma, Inc. is recalling two lots of Lidocaine HCl Topical Solution USP 4%, 50ml to the user level due to super potency, the U.S. Food and Drug Administration said. The product is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract.
Follow RTT